U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C45H48ClN7O8S
Molecular Weight 882.423
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LISAFTOCLAX

SMILES

[O-][N+](=O)C1=CC(=CC=C1NC[C@H]2COCCO2)S(=O)(=O)NC(=O)C3=CC=C(C=C3OC4=CN=C5NC=CC5=C4)N6CCN(CC7=C(CC8(CCC8)CC7)C9=CC=C(Cl)C=C9)CC6

InChI

InChIKey=FNBXDBIYRAPDPI-BHVANESWSA-N
InChI=1S/C45H48ClN7O8S/c46-33-4-2-30(3-5-33)39-25-45(12-1-13-45)14-10-32(39)28-51-16-18-52(19-17-51)34-6-8-38(42(23-34)61-35-22-31-11-15-47-43(31)49-26-35)44(54)50-62(57,58)37-7-9-40(41(24-37)53(55)56)48-27-36-29-59-20-21-60-36/h2-9,11,15,22-24,26,36,48H,1,10,12-14,16-21,25,27-29H2,(H,47,49)(H,50,54)/t36-/m0/s1

HIDE SMILES / InChI

Molecular Formula C45H48ClN7O8S
Molecular Weight 882.423
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:05:21 GMT 2023
Edited
by admin
on Sat Dec 16 14:05:21 GMT 2023
Record UNII
OSL3FEZ1IF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LISAFTOCLAX
INN  
Official Name English
BENZAMIDE, 4-(4-((6-(4-CHLOROPHENYL)SPIRO(3.5)NON-6-EN-7-YL)METHYL)-1-PIPERAZINYL)-N-((4-(((2S)-1,4-DIOXAN-2-YLMETHYL)AMINO)-3-NITROPHENYL)SULFONYL)-2-(1H-PYRROLO(2,3-B)PYRIDIN-5-YLOXY)-
Systematic Name English
APG-2575
Code English
lisaftoclax [INN]
Common Name English
4-(4-((6-(4-CHLOROPHENYL)SPIRO(3.5)NON-6-EN-7-YL)METHYL)-PIPERAZIN-1-YL)-N-((3-NITRO-4-(((2S)-1,4-DIOXAN-2-YLMETHYL)AMINO)PHENYL)SULFONYL)-2-(1HPYRROLO(2,3-B)PYRIDIN-5-YLOXY)BENZAMIDE
Systematic Name English
APG2575
Code English
Lisaftoclax [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 796420
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
FDA ORPHAN DRUG 757920
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
FDA ORPHAN DRUG 772320
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
FDA ORPHAN DRUG 787920
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
Code System Code Type Description
CAS
2180923-05-9
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
NCI_THESAURUS
C156249
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
PUBCHEM
137355972
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
INN
11787
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
FDA UNII
OSL3FEZ1IF
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
SMS_ID
300000031959
Created by admin on Sat Dec 16 14:05:22 GMT 2023 , Edited by admin on Sat Dec 16 14:05:22 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IC50
TARGET -> INHIBITOR
Disruption of Bcl-2-BIM complex and release of pro-apoptotic BIM
IC50
Related Record Type Details
ACTIVE MOIETY